Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01018_DB06414> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01018_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01018_DB06414 label "DDI between Guanfacine and Etravirine - Guanfacine, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to increase guanfacine dosage up to 8mg/day, as tolerated, and to monitor gefitinib therapy. [drugbank_resource:DB01018_DB06414]" assertion.
- drugbank_resource:DB01018_DB06414 identifier "drugbank_resource:DB01018_DB06414" assertion.
- drugbank_resource:DB01018_DB06414 title "DDI between Guanfacine and Etravirine - Guanfacine, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to increase guanfacine dosage up to 8mg/day, as tolerated, and to monitor gefitinib therapy." assertion.